Supernus Pharmaceuticals Inc (SUPN)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 167.84M | 155.41M | 134.77M | 154.34M | 164.52M | 144.74M | 172.68M | 176.71M |
営業利益 | 32.44M | 5.18M | -17.59M | 8.14M | -996k | -3.15M | 22.57M | 40.85M |
税引前収入 | 35.14M | 9.02M | -17.13M | 9.89M | 990k | 243k | 26.3M | 44.94M |
純利益 | 25.48M | 16.95M | -831k | -15.98M | 1.18M | 124k | 19.92M | 38.5M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 32.44M | 5.18M | -17.59M | 8.14M | -996k | -3.15M | 22.57M | 40.85M |
EBITDA | 53.85M | 25.78M | 3.14M | 30.03M | 40.84M | 17.6M | 43.29M | 60.95M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 215M | 302.24M | 408.9M | 392.76M | 520.4M | 586.31M | 667.75M | 609.04M |
営業利益 | 54.22M | 99.54M | 144.44M | 148.57M | 173.7M | 86.03M | 46.12M | -5.27M |
税引前収入 | 50.37M | 100.62M | 140.18M | 147.49M | 168.65M | 73.18M | 60.74M | 2.77M |
純利益 | 91.22M | 57.28M | 110.99M | 113.06M | 126.95M | 53.42M | 60.71M | 1.32M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 1.825 | 1.116 | 2.122 | 2.152 | 2.401 | 1.003 | 1.119 | 0.024 |
EBIT | 53.53M | 99.25M | 144.44M | 148.57M | 173.7M | 86.03M | 46.12M | -5.27M |
EBITDA | 56.62M | 107.64M | 151.54M | 155.23M | 193.7M | 118.62M | 131.67M | 99.78M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約